AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20357732
Drug: Combined immunosuppressants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined immunosuppressants for crescentic poststreptococcal glomerulonephritis
Trial: 15616085
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia (GA) and postoperative opioid analgesia (morphine 0.1 mg/kg bolus and patient‐controlled infusion)
Trial: 15616085
Drug: GA and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GA and paravertebral anesthesia and analgesia (PVAA) (72‐h infusion)
Trial: 15616085
Drug: GA and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GA and postoperative opioid analgesia (morphine 0.1 mg/kg bolus and patient‐controlled infusion)
Trial: 8560160
Drug: 0.05% levocabastine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% levocabastine nasal spray, twice daily for four weeks
Trial: 8560160
Drug: Placebo nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo nasal spray, twice daily for four weeks
Trial: 2231883
Drug: Carboplatin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboplatin (400 mg/m² every 28 days)
Trial: 2231883
Drug: CHIP (270
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHIP (270 mg/m² every 28 days)
Trial: 673643
Drug: Rational-emotive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rational-emotive therapy with rational-emotive imagery
Trial: 673643
Drug: Rational-emotive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rational-emotive therapy without imagery
Trial: 27807903
Drug: Sodium oxybate
RxNorm normalized name: Sodium Oxybate
DrugBank: Sodium oxybate (DB09072)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium oxybate 4.5 g
Trial: 27807903
Drug: Sodium oxybate
RxNorm normalized name: Sodium Oxybate
DrugBank: Sodium oxybate (DB09072)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium oxybate 6 g
Trial: 27807903
Drug: Sodium oxybate
RxNorm normalized name: Sodium Oxybate
DrugBank: Sodium oxybate (DB09072)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium oxybate 9 g
Trial: 26303520
Drug: Perioperative antibiotic
RxNorm normalized name: ENSURE SURGERY PERIOPERATIVE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative antibiotic prophylaxis with ciprofloxacin 2 × 500 mg p.o. for 5 days
Trial: 26303520
Drug: No perioperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No perioperative antibiotic prophylaxis
Trial: 18573923
Drug: Medication management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication management alone (MedMgt)
Trial: 18573923
Drug: Behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavior therapy alone (Beh)
Trial: 18573923
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of medication management and behavior therapy (Comb)
Trial: 18573923
Drug: Community comparison
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community comparison of treatment 'as usual' (CC)
Trial: 16491266
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg BH4
Trial: 16491266
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg BH4
Trial: 12919178
Drug: Zolpidem (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem (5 mg oral dose) in elderly men
Trial: 12919178
Drug: Zolpidem (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem (5 mg oral dose) in young men
Trial: 12919178
Drug: Zolpidem (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem (5 mg oral dose) in elderly women
Trial: 12919178
Drug: Zolpidem (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem (5 mg oral dose) in young women
Trial: 9203230
Drug: m-Chlorophenylpiperazine (mCPP,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: m-Chlorophenylpiperazine (mCPP, 0.1 mg/kg)
Trial: 8202885
Drug: Combined nebulised
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined nebulised salbutamol (5 mg/dose) and aminophylline infusion (0.6‐0.9 mg/kg/hour)
Trial: 8202885
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (salbutamol + aminophylline)
Trial: 3300103
Drug: Intra-arterial chemotherapy
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial chemotherapy with MTX and 5-FU followed by systemic CMFV chemotherapy (therapy arm A)
Trial: 3300103
Drug: Systemic CMFV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic CMFV chemotherapy only (therapy arm B)
Trial: 25909788
Drug: Cellex (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cellex (0.1 mg subcutaneously once a day for the first 10 days and from 21 to 27 days)
Trial: 23355629
Drug: Olmesartan (10-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan (10-40 mg daily)
Trial: 23355629
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (not including ARBs or ACE inhibitors)
Trial: 19679450
Drug: 1 Hz
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 Hz rTMS treatment of the left temporo‐parietal region
Trial: 19679450
Drug: 1 Hz
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 Hz rTMS treatment of the bilateral temporo‐parietal regions
Trial: 19679450
Drug: Combined rTMS
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined rTMS treatment (bilateral and left)
Trial: 10773500
Drug: Dolasetron 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolasetron 25 mg
Trial: 14595183
Drug: Dolasetron 50
RxNorm normalized name: dolasetron 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolasetron 50 mg
Trial: 1795004
Drug: Oral ifosfamide
RxNorm normalized name: Ifosfamide
DrugBank: Ifosfamide (DB01181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ifosfamide (1 g/m2 or 1.5 g/m2)
Trial: 1795004
Drug: Intravenous ifosfamide
RxNorm normalized name: Ifosfamide
DrugBank: Ifosfamide (DB01181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ifosfamide (1 g/m2 or 1.5 g/m2)
Trial: 1795004
Drug: Oral ifosfamide
RxNorm normalized name: Ifosfamide
DrugBank: Ifosfamide (DB01181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ifosfamide
Trial: 1795004
Drug: Intravenous ifosfamide
RxNorm normalized name: Ifosfamide
DrugBank: Ifosfamide (DB01181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ifosfamide
Trial: 6321674
Drug: Synthetic long-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic long-acting ACTH (1 mg IM given 24 hours, 12 hours, and immediately preceding cisplatin)
Trial: 6321674
Drug: Chlorpromazine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (50 mg IM)
Trial: 31672419
Drug: Oral transmucosal
RxNorm normalized name: Thrive, 2 mg oral transmucosal gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral transmucosal dexmedetomidine 0.5 µg.kg−1 (Group DEX I)
Trial: 31672419
Drug: Oral transmucosal
RxNorm normalized name: Thrive, 2 mg oral transmucosal gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral transmucosal dexmedetomidine 1 µg.kg−1 (Group DEX II)
Trial: 31672419
Drug: Oral transmucosal
RxNorm normalized name: Thrive, 2 mg oral transmucosal gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral transmucosal dexmedetomidine (both DEX I and DEX II)
Trial: 28901678
Drug: Cognitive behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioural therapy (CBT) based treatment as usual
Trial: 21605352
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care (laser iridotomy surgery and medical treatment)
Trial: 19397664
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream (Aqueous)
Trial: 16940886
Drug: Omeprazole 60
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole 60 mg + pancreatic enzymes 10,000 IU lipase tid (treatment A)
Trial: 16940886
Drug: Omeprazole 60
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole 60 mg + pancreatic enzymes 20,000 IU lipase tid (treatment B)
Trial: 3995531
Drug: Clebopride (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clebopride (2 mg)
Trial: 30926986
Drug: Decaffeinated green
RxNorm normalized name: (-)-EPIGALLOCATECHIN-3-O-GALLATE (EGCG) (CONSTITUENT OF POWDERED DECAFFEINATED GREEN TEA EXTRACT) [DSC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decaffeinated green tea extract (GTE) - 4 capsules containing 1315 mg total catechins including 843 mg epigallocatechin‐3‐gallate daily for 1 year
Trial: 30926986
Drug: Placebo -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo - similar capsules containing no tea catechins
Trial: 28427299
Drug: Low-frequency rTMS
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-frequency rTMS + Physical Therapy (PT)
Trial: 24866258
Drug: Educational intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Educational intervention on folic acid (FA) supplements at the 6-month visit.
Trial: 21654755
Drug: Azelnidipine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelnidipine (8 mg/day increased to 16 mg/day)
Trial: 21654755
Drug: Amlodipine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (2.5 mg/day increased to 5 mg/day)
Trial: 9180240
Drug: Atorvastatin (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (2.5, 5, 10, 20, 40, or 80 mg/day)
Trial: 8299665
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg of powdered garlic (coated tablets) daily for 4 weeks
Trial: 24358287
Drug: Hypnotic suggestion
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic suggestion of ingesting an appetizing meal
Trial: 24358287
Drug: Hypnotic suggestion
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic suggestion of ingesting an unappetizing meal
Trial: 16627459
Drug: Ramp therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramp therapy
Trial: 16627459
Drug: Medication toxicity
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication toxicity
Trial: 2677123
Drug: Various treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various treatments for C. pylori gastritis and NUD
Trial: 309095
Drug: Combined prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined prednisone (29 mg/day) and cyclophosphamide (107 mg/day) for six months
Trial: 309095
Drug: Prednisone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (40 mg/day) for six months
Trial: 21550959
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro mix 75/25
Trial: 21550959
Drug: Metformin/thiazolidinedione
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin/thiazolidinedione
Trial: 21550959
Drug: Metformin/sulfonylurea/thiazolidinedione
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin/sulfonylurea/thiazolidinedione
Trial: 16541243
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg caffeine
Trial: 16541243
Drug: 450 mg
RxNorm normalized name: aspirin 450 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 450 mg caffeine
Trial: 3222359
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg caffeine (control)
Trial: 16541243
Drug: All caffeine
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All caffeine doses (50, 150, 450 mg)
Trial: 3793549
Drug: 60 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg/m2 of doxorubicin every 3 weeks for eight courses
Trial: 3793549
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy (optional)
Trial: 26522923
Drug: Pulmonary Rehabilitation
RxNorm normalized name: Lobaria pulmonaria extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulmonary Rehabilitation plus hyperproteic oral nutritional supplement enriched with HMB (PRONS)
Trial: 24439972
Drug: Triple Pill
RxNorm normalized name: Triple Wormer Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple Pill (initially strength 1-telmisartan 20 mg, amlodipine 2.5 mg, hydrochlorothiazide 6.25 mg, with the option of subsequent titration to strength 2-telmisartan 40 mg, amlodipine 5 mg, hydrochlorothiazide 12.5 mg)
Trial: 15999098
Drug: Fixed-dose rate
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose rate gemcitabine
Trial: 12453952
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg glipizide (30 min premeal)
Trial: 12453952
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg nateglinide (15 min premeal)
Trial: 12453952
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg glipizide plus 120 mg nateglinide (30 and 15 min premeal, respectively)
Trial: 9768208
Drug: Heberbiovac HB
RxNorm normalized name: Citalopram Hydrobromide
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heberbiovac HB vaccine
Trial: 9768208
Drug: Engerix-B vaccine
RxNorm normalized name: Engerix-B
DrugBank: Hepatitis B Vaccine (Recombinant) (DB11627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Engerix-B vaccine (control)
Trial: 30080248
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of unfavorable criteria
Trial: 27084855
Drug: Oral amoxicillin
RxNorm normalized name: amoxicillin Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amoxicillin 1 gm, 1 hour preoperatively and 2 gm for 2 days postoperatively (Test group)
Trial: 24799054
Drug: trastuzumab (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: trastuzumab (4 mg/kg), gemcitabine (1000 mg/m(2)), docetaxel (50 mg/m(2))
Trial: 18758336
Drug: New mothers'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New mothers' support group with one-on-one teaching prenatally and weekly meetings postpartum, taught by a lactation consultant and a pediatrician
Trial: 22814329
Drug: Intravenous amphotericin
RxNorm normalized name: amphotericin
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous amphotericin B lipid complex (ABLC) 7.5 mg/kg weekly
Trial: 22814329
Drug: Oral posaconazole
RxNorm normalized name: Posaconazole
DrugBank: Posaconazole (DB01263)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Oral posaconazole 200 mg three times per day
Trial: 17983400
Drug: 16‐week regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16‐week regimen (weekly therapy with cytoxan, adriamycin, vincristine, methotrexate, and 5‐FU)
Trial: 15727949
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) alone
Trial: 15727949
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) plus Testosterone (T)
Trial: 15727949
Drug: Testosterone (T)
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone (T) plus Growth Hormone (GH)
Trial: 15727949
Drug: Combined treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatments (GH and T)
Trial: 12402373
Drug: 2 ml
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 ml saline instillation
Trial: 12402373
Drug: 5 ml
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml saline instillation
Trial: 12402373
Drug: 0 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 ml saline instillation (no saline)
Trial: 8074058
Drug: Diluted meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diluted meal (2671 kJ/L, 950 mL)
Trial: 8074058
Drug: Concentrated meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concentrated meal (7452 kJ/L, 350 mL)
Trial: 7114587
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (500 mg)
Trial: 25641731
Drug: Simultaneous dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simultaneous dosage of ascorbic acid and aspirin
Trial: 23732903
Drug: Pentavalent rotavirus
RxNorm normalized name: Vaccine product containing only live pentavalent Rotavirus antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentavalent rotavirus vaccine RV5 (RotaTeq™), 3-dose regimen
Trial: 12928710
Drug: Prostaglandin E(1)
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prostaglandin E(1) injection before CTAP
Trial: 12928710
Drug: No prostaglandin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No prostaglandin E(1) injection (group A)
Trial: 11211541
Drug: Monthly structured
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly structured interventions for six months (Group 1, n = 42)
Trial: 22901308
Drug: SAMe 1600
RxNorm normalized name: SAMe
DrugBank: Ademetionine (DB00118)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAMe 1600 mg
Trial: 22901308
Drug: SAMe 800
RxNorm normalized name: SAMe
DrugBank: Ademetionine (DB00118)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAMe 800 mg
Trial: 15887009
Drug: Valdecoxib 20
RxNorm normalized name: valdecoxib 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valdecoxib 20 mg single dose on day 1 and 20 mg twice daily on days 4-7, followed by a single morning dose on day 8.
Trial: 9799756
Drug: Cyclic or
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclic or continuous hormone replacement therapy (HRT) with an estrogen analog (tibolone)
Trial: 2199209
Drug: Inhaled frusemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled frusemide (approximately 28 mg)
Trial: 23689947
Drug: GHRH (tesamorelin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRH (tesamorelin, 1 mg/d)
Trial: 18483726
Drug: Donepezil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (5 mg/day after an induction period of 3 mg/day for 2 weeks)
Trial: 11951094
Drug: Cilostazol 50
RxNorm normalized name: cilostazol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilostazol 50 mg twice daily
Trial: 7885426
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (800 micrograms)
Trial: 2198211
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg sultamicillin (STM) b.i.d.
Trial: 2198211
Drug: 625 mg
RxNorm normalized name: betaine 625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 625 mg amoxicillin/clavulanate (AMX/CLA) t.i.d.
Trial: 333869
Drug: Calcium clofibrate
RxNorm normalized name: Clofibrate
DrugBank: Clofibrate (DB00636)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium clofibrate (2 g)
Trial: 21041163
Drug: Cholestyramine (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine (12 g)
Trial: 333869
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of calcium clofibrate and calcium carbonate (2 + 2 g)
Trial: 28012035
Drug: Sorafenib (4-week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib (4-week treatment prior to surgery)
Trial: 28012035
Drug: Placebo (4-week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (4-week treatment prior to surgery)
Trial: 25359924
Drug: Interferon-alpha (IFN-α)
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha (IFN-α) antiviral therapy
Trial: 19786646
Drug: Sesame supplementation
RxNorm normalized name: Sesame Oil
DrugBank: Sesame oil (DB11172)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sesame supplementation (25 g/d of sesame, approximately 50 mg/d of sesame lignan)
Trial: 15182126
Drug: Propranolol (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.05 mg/kg)
Trial: 11429668
Drug: Ranitidine bismuth
RxNorm normalized name: RANITIDINE BISMUTH CITRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine bismuth citrate (RBC) in combination with clarithromycin for 14 days